CANADABIS CAPITAL INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.09 CAD | -10.00% |
|
-10.00% | -64.71% |
| May. 07 | Canadabis Capital Signs Pact to Expand Into Europe | MT |
| May. 07 | CanadaBis Capital Brief: Expanding into European Market with EU-GMP Partners | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 11.67 15.9 | Sales 2023 | 22.22 30.28 | Capitalization | 40.08M 54.62M |
|---|---|---|---|---|---|
| Net income 2022 | - 0 | Net income 2023 | 4M 5.45M | EV / Sales 2022 | 1,124,727 x |
| Net Debt 2022 | 8.32M 11.34M | Net Debt 2023 | 4.74M 6.46M | EV / Sales 2023 | 2,016,843 x |
| P/E ratio 2022 |
7.87
x | P/E ratio 2023 |
8.95
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 31.41% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -10.00% | ||
| 1 week | -10.00% | ||
| Current month | +5.88% | ||
| 1 month | +12.50% | ||
| 3 months | -61.70% | ||
| 6 months | -67.86% | ||
| Current year | -64.71% |
1 week
0.09
0.10
1 month
0.070.11
Current year
0.070.28
1 year
0.070.35
3 years
0.030.35
5 years
0.030.52
10 years
0.030.68
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 19-04-25 | |
| Director of Finance/CFO | - | 21-12-31 | |
Shane Chana
BRD | Director/Board Member | - | 20-01-14 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Barbara O'Neill
BRD | Director/Board Member | 56 | 16-11-28 |
| Director/Board Member | 44 | 23-05-31 | |
Alex Michaud
BRD | Director/Board Member | - | 19-03-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 0.09 | -10.00% | 37,700 |
| 24-05-16 | 0.1 | +5.26% | 2,000 |
| 24-05-15 | 0.095 | 0.00% | 3,000 |
| 24-05-14 | 0.095 | -5.00% | 80,007 |
Delayed Quote Toronto S.E., May 17, 2024 at 03:28 pm EDT
More quotes
CanadaBis Capital Inc. is a vertically integrated Canadian cannabis company. The Companyâs principal business is the production and sale of recreational cannabis and cannabis extracts. The Company operates through three segments: Cultivation and wholesale, Retail and Extract. The Cultivation and wholesale segment is engaged in cultivating and distributing cannabis and cannabis products to and through, provincial liquor and cannabis boards, which are subsequently sold to end consumers. Its Retail segment is involved in the sale of cannabis and cannabis related products to end consumers on premise owned and operated by the Company. Its Extract segment provides cannabinoid extraction services for the Company and also to other licensed producers. The Companyâs subsidiaries include Stigma Pharmaceuticals Inc., 1998643 Alberta Ltd., Full Spectrum Labs Ltd., 2103157 Alberta Ltd., and Goldstream Cannabis Inc.
Sector
Drug Retailers
Calendar
2024-06-26
- Q3 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -64.71% | 9.14M | |
| +18.70% | 3.07B | |
| +18.71% | 1.77B | |
| +97.67% | 671M | |
| +11.82% | 527M | |
| +40.38% | 174M | |
| -2.51% | 94.81M | |
| -9.02% | 94.91M | |
| +37.50% | 63.28M | |
| +40.45% | 57.02M |
- Stock Market
- Equities
- CANB Stock
